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Abstract
Introduction
Schistosomiasis is one of the neglected tropical diseases targeted for elimination in Uganda
through the Mass Drug Administration (MDA) programme. Praziquantel has been distribut-
ed using community resource persons in fixed sites and house-to-house visits; however the
uptake is still below target coverage. In 2011/2012 MDA exercise, uptake stood at 50% yet
WHO target coverage is 75% at community level. We assessed the uptake of MDA and the
associated factors in Koome Islands, Central Uganda.
Methods
In March 2013, we conducted a mixed methods cross sectional study in 15 randomly select-
ed villages. We interviewed a total of 615 respondents aged 18 years and above using semi
structured questionnaires and five key informants were also purposively selected. Univari-
ate and multivariate analysis was done. MDA uptake was defined as self reported swallow-
ing of praziquantel during the last (2012) MDA campaign. We conducted key informant
interviews with Ministry of Health, district health personnel and community health workers.
Results
Self reported uptake of praziquantel was 44.7% (275/615), 95% confidence interval (CI)
40.8–48.7%. Of the 275 community members who said they had swallowed praziquantel,
142 (51.6%) reported that they had developed side effects. Uptake of MDA was more likely
if the respondent was knowledgeable about schistosomiasis transmission and prevention
(adjusted odds ratio [AOR] 1.85, 95% CI 1.22–2.81) and reported to have received health
education from the health personnel (AOR 5.95, 95% CI 3.67–9.65). Service delivery chal-
lenges such as drug shortages and community health worker attrition also influenced MDA
in Koome Islands.
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Conclusions
Uptake of MDA for schistosomiasis control in Koome was sub optimal. Lack of knowledge
about schistosomiasis transmission and prevention, inadequate health education and drug
shortages are some of the major factors associated with low uptake. These could be ad-
dressed through routine health education and systematic drug supply for the successful
elimination of schistosomiasis on the islands.
Introduction
Schistosomiasis is one of the Neglected Tropical Diseases (NTDs) that cause significant public
health problems, particularly in developing countries, where poverty, poor nutrition, inade-
quate sanitation, lack of clean drinking water and minimal health care prevail [1].
In Uganda, about four million people are infected with schistosomes and almost 17 million
are at risk of infection[2]. Schistosomiasis is endemic in 86 districts in Uganda [3], and is par-
ticularly a problem in fishing communities which are of high economic importance in, since
the fishing industry contributes 2.5% to Uganda’s Gross Domestic Product (GDP) [4].
Schistosoma mansoni (which causes intestinal schistosomiasis) is the most common species
in Uganda. This species causes lesions of the liver, and intestine [5]. In most people, schistoso-
miasis causes chronic, subtle morbidity, which may go unnoticed. In severe cases, liver damage
leads to periportal fibrosis, portal hypertension, hepato-splenomegaly, ascites and esophageal
varices, and can cause death of the affected person [6]. Schistosomiasis may also cause chronic
growth faltering and can contribute to anemia.
The World Health Organization’s strategic plan of 2012 proposed scaling up of Mass Drug
Administration (MDA) as a means of controlling schistosomiasis morbidity by 2020 [7] and
schistosomiasis is one of the NTDs targeted for elimination in Uganda through the MDA pro-
gramme [8]. MDA using praziquantel (PZQ) reduces morbidity from schistosomiasis by de-
creasing the intensity of infection and limiting transmission within endemic communities [9].
Uganda has adopted a strategy of school-based MDA supplemented by a community compo-
nent to effectively reach children who are not in school and the other community members.
Large scale MDA of praziquantel has been shown to achieve substantial reductions in S.man-
soni re-infection and community transmission in Uganda [10].
The National Bilharzia Control Programme, under the Neglected Tropical Diseases (NTD)
programme is implemented at district level through the District Health Office (DHO) by the
District Vector Control Officer (DVCO) and the District Health Educator (DHE). Community
Resource Persons known as Village Health Team (VHT) members are utilized in MDA activi-
ties and social mobilization services [8].
Two VHTs are trained per village by sub county supervisors. The training equips VHTs
with knowledge on health education issues, causes, signs, symptoms and transmission of schis-
tosomiasis, management of side effects and referral of advanced schistosomiasis cases [11]. The
training aims to equip the VHTs with the necessary knowledge and skills and to enable them to
effectively mobilize community members for health action. The VHTs are given registers, dos-
ing poles and drugs during MDA implementation activities.
In the community, the VHTs are expected to register all household members in the Ministry
of Health NTD register where the name of the individual and their age are recorded. During
the administration of the drug, some VHTs use the stationary point or mass gathering mode of
delivery while others use the mobile or house-to-house mode of delivery. After an individual
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has received and /or swallowed the antihelminthic drug (PZQ), the VHT member records in
the register.
Mukono district is one of the schistosomiasis endemic communities in Uganda. The infec-
tions are mostly prevalent along the shores of Lake Victoria [12]. Koome Islands are one of the
highly burdened areas in Mukono with a prevalence of over 50% [12] and are a recognized
“hard to reach” community [13]. Since 2003, MDA has been implemented annually in Koome
Islands but uptake of PZQ is still below the 75%WHO recommended target coverage (at only
50% in the 2011/2012 MDA [14].
We conducted this study to find out why uptake remains low and inform efforts of the Vec-
tor Control Division (VCD), Ministry of Health (MoH) and implementation partners in de-
signing and evaluating interventions aimed at increasing uptake of MDA in schistosomiasis
endemic areas.
Materials and Methods
Study setting
In March 2013, we conducted a mixed methods cross sectional study among adults living on
Koome Islands on Lake Victoria, an endemic sub county that lies approximately 35 km by
water east of Entebbe, the nearest large town. Koome is made up of four parishes with a total of
30 villages which are dispersed across the islands with an estimated total population of 12300
people. Each village is made up of approximately 100 households mostly of temporary struc-
tures. The principal economic activity on the islands is fishing.
The study was conducted in Koome Islands, within one year after the 2012 annual MDA
which had been conducted between April and June 2012 by the VHTs. Specifically, we sought
to estimate the uptake of PZQ among adults during the last MDA, identify population factors
associated with uptake of MDA and identify the service delivery factors influencing uptake of
MDA.
Schistosomiasis is endemic in Koome Islands and MDA is an annual event. Under the NTD
programme, the drugs were delivered to all the sampled villages during the time of the MDA
exercise so in theory anyone living in the village could have taken them with a small amount of
effort. We therefore assumed that everyone had the opportunity to take the drug during the
last 2012 MDA
Study population and sampling
Fifteen villages were chosen by random selection from a list of all 30 villages using STATA
with stratification to ensure representation of villages near the sub county health center and
those that are far from the health center.
We aimed to recruit 615 participants, one per household, including 41 households in each
selected village. To do this, the total number of households in each of the selected villages was
obtained from the Local Chairperson (LC-1) and a sampling interval was calculated by dividing
the total number of households per village by the number of households targeted for inclusion
in each village. The starting point in each village was selected randomly by spinning a pen in
the center of the village. The nearest household in the direction pointed by the pen was selected
as the starting point.
Eligible respondents were adults who had lived on the islands for more than 12 months and
were willing to participate in the study. At each selected household, eligible adults were listed
and one adult was chosen to participate by ballot. If a household had no adults who met our in-
clusion criteria, the next household was selected.
Uptake of Mass Treatment
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Five key informants were purposively selected and interviewed about the factors that influ-
ence the uptake of the MDA intervention in Koome. Key informants were selected from each
of the following offices: the district vector control office, village health teams, district NTD
focal office, the Ministry of Health Vector Control Division and community leaders. These
were chosen based on the fact that they had an expert opinion about the factors that influence
uptake of MDA.
Measurement of variables
Both qualitative and quantitative data were collected.
For the quantitative analysis, data were collected using a pretested semi-structured ques-
tionnaire which was developed based on the modified Anderson model of health service utili-
zation [15] with themes on individual, enabling and perception factors associated with uptake
of MDA. The questionnaire was administered to the adults in the local language (Luganda) by
trained research assistants.
As a population level intervention, the outcome was uptake of MDA, defined as the propor-
tion of individuals in the sampled population who self reported to have swallowed praziquantel
in the last MDA exercise of 2012.
Respondents were also assessed for socio demographic characteristics, exposure to health
education and level of knowledge about MDA and schistosomiasis. The latter was determined
using a score constructed of six variables with equal weight in the score. Based on the WHO
recommendation for the control of schistosomiasis, these knowledge variables covered three
main components: drug treatment, sanitation and information about control of transmission
and re-infection by self protective behavior [16]. A total score of 4–6 was considered high level
of knowledge and 0–3 as low level of knowledge.
Additional individual perceptions about schistosomiasis and MDA were measured on a five
point Likert scale [17] to quantify responses to perception statements with lower scores of 1 to
3 representing negative perceptions and higher scores 4 to 5 representing positive perceptions.
For the qualitative analysis, service delivery factors were assessed through key informant in-
terviews with service providers. The key informant interviews focused on four health system
themes suspected of influencing MDA in Koome. The themes were financing, service delivery,
drug supply and human resources for health.
Statistical considerations
The sample size required was estimated based on our first objective, which was to determine the
uptake of praziquantel during mass drug administration among adults in Koome sub-county.
Using a formula by Kish [18], assuming coverage of approximately 50%, and a design effect of
1.58 (to allow clustering by village) a sample size of 607 participants was required to estimate up-
take with a precision of +/- 5%.We sampled 615 respondents to cater for non response.
Questionnaires were entered in EPI data and analyzed in STATA version 10. Univariate
analysis was done to determine uptake and multivariate analysis using backward elimination
method was done to determine factors independently associated with uptake. All the variables
considered have been shown in the tables for the univariate analysis. These were informed by
our conceptual framework developed based on the modified Anderson model of health service
utilization [15].
In multivariate analysis, we used the p-value-driven approach to select the covariates to
keep in the model. After fitting the full model with all covariates based on our conceptual
framework, we removed in each step the covariates with the largest p-values until all covariates
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had a p-value less than 0.05. Crude and adjusted odds ratios with their corresponding 95% con-
fidence intervals and p-values were generated.
For qualitative data, transcriptions from the audio recordings formed the empirical basis for
the content analysis. Transcripts were first read several times to obtain an overall picture and
then coded in order to identify recurring themes. Key quotations that epitomized central
themes relating to the health system were identified.
Ethics
Written informed consent was sought from each individual before the questionnaire or key in-
formant interview was administered. No personal identifiers were collected.
This study was approved by the Institutional Review Board of Makerere University School
of Public Health Higher Degrees, Research and Ethics Committee.
Results
A total of 615 respondents sampled from 15 villages were interviewed. Five key informant in-
terviews were conducted
Socio-demographic characteristics
The socio-demographic characteristics of the respondents that participated in the question-
naire survey are shown in Table 1. Over half (56.9%) of the respondents were male.
Table 1. Respondents’ socio demographic characteristics.
VARIABLE FREQUENCY N = 615 PERCENTAGE (%)
Age group (years)
18–24 134 21.8
25–29 132 21.5
30–39 220 35.8
40+ 129 21
Length of stay in the village (Years)
1–2 178 28.9
3–5 184 29.9
>5 253 41.1
Highest education level
None 153 24.9
Primary 321 52.2
Secondary 138 22.4
Tertiary 3 0.5
Occupation
Fisherfolks 219 35.6
Business 186 30.2
Agriculture 131 21.3
Casual labourer 25 4.1
Others 54 8.8
Marital status
Married 413 67.2
Single 93 15.1
Separated 88 14.3
Widowed 21 3.4
doi:10.1371/journal.pone.0123673.t001
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Respondents’ age ranged from 18 to 86 with a mean age of 32 years (SD = ±10.8). Most respon-
dents (52.2%) had received primary education and the majority (67.2%) reported that they
were married. Most respondents (35.6%) were “fisherfolk”- that is, involved in occupation re-
lated to the fishing industry.
Uptake of MDA
In all the 15 sampled villages, distribution of praziquantel was conducted in the 2012 MDA ex-
ercise. Eight villages out of the 15 had conducted house to house administration while the rest
conducted mass gathering administration. Of the total number of 615 respondents, only 285
respondents (46.3%) reported that they had participated in the MDA exercise and 275 of them
reported that they had ingested the drug. The overall reported uptake of MDA among the
study participants was 44.7% (275/615), 95% confidence interval (CI) 40.8%-48.7%. Of the 275
community members who said they had swallowed praziquantel, 142 (51.6%) reported that
they had developed side effects.
Factors associated with reported uptake of praziquantel in the univariate analysis are shown
in Tables 2 and 3. Older age group (age of 40 years or above) was associated with swallowing
the drugs (OR 1.70, 95% CI 1.04–2.78) and being in a fishing occupation had a positive associa-
tion with uptake of mass treatment (OR 1.50, 95% CI 1.07–2.09). Enabling factors such as
knowledge about MDA and receiving health education were significantly associated with up-
take of MDA (Table 2).
With regard to perception factors (Table 3) respondents who agreed that MDA improves
one’s health were more likely to swallow schistosomiasis drugs (OR 9.16, 95% CI 1.17–71.40).
It was also noted that some negative perceptions such fear of the side effects and the bad taste
of the schistosomiasis drugs were positively associated with swallowing the drug (OR 2.72, 95%
CI 1.86–3.96 and OR 7.37, 95% CI 4.95–10.98 respectively).
In the multivariate analysis (Table 4) age and length of stay in the village were no longer im-
portant but knowledge and education about schistosomiasis remained strongly associated with
uptake, as did positive perceptions of health benefit, as well as awareness of negative aspects of
praziquantel treatment such as bad taste.
Service delivery factors
Service delivery factors were highlighted through the key informant interviews. All the five key
informants had acquired secondary education and above and had participated in conducting
MDA exercises within Koome sub county and other parts of Uganda.
Poor acceptability of the drugs was noted as a major service delivery challenge. During the
key informant interviews (KIIs) it was revealed that some community members complain
about the drugs and it is one of the reasons why some community members may refuse the
drugs: "The drugs are big and they are too many depending on one's height so people do not like
them, the government should decrease the size of the tablet and give one with the required milli-
grams for each person and provide drinking water so that people swallow immediately they re-
ceive under observation, otherwise they do not swallow from home and drugs should be made
sweet for children like albendazole" (VHT in Kansambwe).
Out of the 5 key informant interviews, 3 mentioned inadequate funding for the island activi-
ties as a major bottleneck in MDA activities since the high operational costs cannot be met.
One key informant said, “We lack facilitation to motivate these VHTs, yet they do a lot of
work” (KI: district vector control office) and the attrition of community drug distributors was
attributed to the lack of incentives.
Uptake of Mass Treatment
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However, the MoH representative revealed that there have been more funders brought on
board to support the schistosomiasis control initiatives: "We have several partners like Research
Triangle International and the Schistosomiasis Control Initiative, and we involve the district in
planning for drug procurement and operational costs.We also have the health education
Table 2. Individual and enabling factors and their association with uptake of MDA.
Variable Uptake of MDA Unadjusted-OR P-value
Yes (n = 275) No(n = 340) 95% CI
N (%) N (%)
Age
18–24 51(18.5) 83(24.4) 1.00
25–29 52(18.9) 80(23.5) 1.06(0.65–1.73)
30–39 106(38.5) 114(33.5) 1.51(0.98–2.34) 0.01*
40+ 66(24.0) 63(18.5) 1.70(1.04–2.78)
Sex
Male 167(60.7) 183(53.8) 1.00
female 108(39.3) 157(46.2) 0.75(0.55–1.04) 0.09
Marital status
Single 41(14.9) 52(15.3) 1.00
Married 188(68.4) 225(66.2) 1.06(0.67–1.67) 0.82**
Other 46(16.7) 63(18.5) 0.92(0.53–1.62)
Education level
None 73(26.6) 80(23.5) 1.00
Primary 137(49.8) 184(54.1) 0.82(0.55–1.20)
Secondary 63(22.9) 75(22.1) 0.92(0.58–1.46) 0.88*
Tertiary 2(0.7) 1(0.3) 2.19(0.19–24.69)
Occupation
Non ﬁshing 149(54.1) 210(61.8) 1.00
Fisher folks 112(40.7) 107(31.5) 1.50(1.07–2.09) 0.02
Length of stay in the village (years)
1–2 59(21.4) 119(35.0) 1.00
3–4 89(32.4) 95(28.0) 1.89(1.23–2.89) 0.001*
>5 127(46.2) 126(37.1) 2.03(1.37–3.03)
Sanitary facility use
Latrine 154(56.0) 162(47.6) 1.00
Bush 121(44.0) 178(52.4) 0.71(0.52–0.98) 0.04
Knowledge about MDA
Not knowledgeable 75(27.3) 199(58.5) 1.00
Knowledgeable 200(72.7) 141(41.5) 3.76(2.67–5.30) <0.001
Ever seen a poster
No 62(22.5) 174(51.2) 1.00
Yes 213(77.5) 166(48.8) 3.60(2.53–5.13) <0.001
Received health education in 2012
No 144(52.4) 297(87.4) 1.00
Yes 131(47.6) 43(12.6) 6.28(4.22–9.35) <0.001
*p-value for trend
**p-value for homogeneity
doi:10.1371/journal.pone.0123673.t002
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programme to inform people about the benefits about MDA thus we have seen an upward trend
in the uptake levels."
Another challenge highlighted was the inadequate drugs and the poor drug distribution sys-
tem for MDA: “I cannot say that the drugs are readily available. . .partly because of funding and
also National Medical Stores is not systematic in their supplies and the drugs do not easily reach
the islands, so the areas near the mainland receive enough while far areas do not” (KI district
vector control office).
Health education activities also face limitations within the islands: "The current health edu-
cation programme of using radios does not work. . .Not all people on the island access radio and
even the film vans are not effective.We should adopt the use of the local public address systems to
mobilize and educate people” (KI: district vector control office).
Table 3. Perception factors associated with uptake of MDA.
Variable Uptake of MDA Unadjusted-OR 95% CI P-value
Yes (n = 275) No (n = 340)
N (%) N (%)
Perceived susceptibility
My risk of catching schistosomiasis
High 151(54.9) 190(55.9) 0.96 (0.70–1.32) 0.81
Low 124(45.1) 150(44.1) 1.00
Perceived severity
Schistosomiasis can cause death
Agree 267(97.1) 325(95.6) 1.54(0.64–3.69) 0.33
Disagree 8 (2.9) 15(4.4) 1.00
Perceived need of MDA
Everyone should swallow schistosomiasis drugs
Agree 266(96.7) 317(93.2) 2.14(0.98–4.71) 0.06
Disagree 9 (3.3) 23(6.8) 1.00
Schistosomiasis drugs cause side effects
Agree 225(81.8) 212(62.4) 2.72(1.86–3.96) <0.001
Disagree 50(18.2) 128(37.6) 1.00
Perceived beneﬁts
Mass treatment is effective in controlling schistosomiasis
Agree 262(95.3) 310(91.2) 1.95(1.00–3.82) 0.05
Disagree 13(4.7) 30(8.8) 1.00
MDA improves ones health
Agree 274(99.6) 329(96.8) 9.16(1.17–71.40) 0.03
Disagree 1(0.4) 11(3.2) 1.00
Treatment during MDA improves one’s ability to work more in the long term
Agree 272(98.9) 328(96.5) 3.32(0.93–11.87) 0.07
Disagree 3(1.1) 12(3.5) 1.00
Perceived barriers
Drugs given in MDA taste very bad
Agree 142(51.6) 43(12.6) 7.37(4.95–10.98) <0.001
Disagree 133(48.4) 297(87.4) 1.00
Treatment by MDA can cause death or bad effects
Agree 73(26.5) 60(17.6) 1.69(1.15–2.48) 0.008
Disagree 202(73.5) 280(82.4) 1.00
doi:10.1371/journal.pone.0123673.t003
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In all of the sampled villages, the VHTs had conducted the MDA exercise. However, among
the 15 villages that we included in the quantitative study, only 8 of the villages (53%) had
VHTs that had been trained prior to the 2012 MDA exercise and only 4 villages (27%) had
VHTs that had received support supervision in the last quarter prior to this study.
Long waiting time was an important factor revealed by a key informant: “One of the chal-
lenges we face during MDA is making the people wait for long at the gathering center since we
only have one dosing pole or keeping the people at home waiting for the VHT visit.” Some decide
not to be delayed and thus do not wait to receive the drug.
Discussion
Uptake of MDA
The uptake of MDA was sub optimal at only 44.7%. WHO notes that it is important to achieve
appropriate coverage of mass treatment in order to avoid high intensity of infection [9], howev-
er coverage in Koome was below the 75% target [19]. With this low coverage elimination of the
disease can hardly be achieved.
Factors associated with uptake of MDA
Occupation was strongly associated with MDA uptake. This is in agreement with several stud-
ies that people in the fishing occupation could have perceived a high susceptibility to the dis-
ease and a high need for the drug due to their exposure [20]. Fisherfolk are the most likely
people to be infected with schistosomiasis, thus the need to continuously target those who fish
or trade in fish in a special way during the MDA exercises to ensure that despite their mobility,
they are not missed during MDA exercises.
Table 4. Factors independently associated with uptake of MDA.
Variable Uptake of MDA Unadjusted-OR 95% CI Adjusted OR 95% CI p-value AOR
Yes (n = 275) No (n = 340)
N (%) N (%)
Knowledge
Knowledgeable 200(72.7) 141(41.5) 3.76(2.67–5.30) 1.85(1.22–2.81) 0.004
Not knowledgeable 75(27.3) 199(58.5) 1.00 1.00
Ever seen a poster
Yes 213(77.5) 166(48.8) 3.60(2.53–5.13) 2.00(1.28–3.14) 0.002
No 62(22.5) 174(51.2) 1.00 1.00
Received health education in 2012
Yes 131(47.6) 43(12.6) 6.28(4.22–9.35) 5.95(3.67–9.65) <0.001
No 144(52.4) 297(87.4) 1.00 1.00
Treatment during MDA improves health
Agree 274(99.6) 329(96.8) 9.16(1.17–71.40) 13.96(1.62–120.41) 0.017
Disagree 1(0.4) 11(3.2) 1.00 1.00
Drugs given in MDA taste very bad
Agree 142 (51.6) 43 (12.6) 7.37(4.95–10.98) 8.17(5.18–12.87) <0.001
Disagree 133 (48.4) 297 (87.4) 1.00 1.00
Occupation
Fisher folk 112(40.7) 107(31.4) 1.50(1.07–2.09) 1.73(1.13–2.63) 0.011
Non ﬁshing 149(54.2) 210(61.8) 1.00 1.00
doi:10.1371/journal.pone.0123673.t004
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Although the drugs have side effects, awareness of this did not deter people from swallowing
them in this study. This may be because the benefits of the drugs outweigh the barrier of side
effects experienced when the drugs are swallowed [21]. However, these findings contradict sev-
eral studies [20, 22–23] which reveal that previous experience or knowledge of side effects im-
pacts adversely on the uptake of mass treatment. Since this was a cross-sectional study, there is
a possibility that this observation was due to the fact that the people who had swallowed the
drugs were most likely to have experienced the side effects and the bad taste and therefore to
remember and be knowledgeable about them. Where possible, it is important to mitigate side
effects among the community members during MDA.
Enabling factors associated with uptake of MDA
Respondents who are knowledgeable about the risks to health and methods of preventing para-
sitic infections were more likely to have complied with mass treatment in this and in previous
studies [22, 24–25]. However, others have shown that knowledge does not always translate into
practice [26]. This mainly results from presence of barriers to change, such as fear of side effects
and long waiting times, and these need to be removed to facilitate compliance to MDA [27].
Most people had not received health education about schistosomiasis and its control during
the 2012 MDA exercise, despite the fact that health education is a major control strategy rec-
ommended as a first step towards creating an enabling environment in which other strategies
can thrive. Inappropriate and inadequate health education has been shown to contribute to re-
jection of free mass treatment [20]. Health education is related to level of knowledge about
MDA, encourages community participation and modifies people’s beliefs towards the pro-
posed control measures [9].
Although general level of education has been found to be associated with the uptake of
health services [22, 25, 28] because it facilitates understanding of health education messages, it
was not a relevant factor in this study.
Perception factors associated with uptake of MDA
Perception that MDA improves health by controlling schistosomiasis related morbidity has
been shown to motivate uptake of MDA [21]. This relates to the health belief model which pro-
poses that when a person perceives themselves to be at risk of acquiring the disease and the
benefits of the intervention are known, if there are no barriers, the intervention is adopted [27].
Perceptions about an intervention are shaped by factors including how benefits are commu-
nicated, how they conform to prevailing beliefs, and perceived legitimacy of the intervention,
and these perceptions affect acceptability of an intervention [29]. This calls for efforts to ensure
that the information available to the community members is appropriate [30].
Service delivery factors associated with uptake of MDA. Service delivery and logistical
challenges such as untrained community drug distributors (VHTs), lack of facilitation to
VHTs, lack of supplies, drug shortages and VHT attrition influenced uptake of MDA in
this study.
In Koome Islands, VHTs were involved in MDA in the sampled villages which showed posi-
tive community involvement. This is very important for buy-in at community level in order to
achieve tangible results in MDA [25]. However, uptake was lower than expected from the NTD
programme, possibly because the VHTs faced challenges: some VHTs had not been trained
and others lacked the necessary supplies and materials such as Information Education and
Communication (IEC) materials to support schistosomiasis control initiatives.
VHTs who are not trained may lack the knowledge and skills to offer adequate health edu-
cation and to address the fears of the population. This can contribute to the failure of the MDA
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health education programme [26]. These findings show the need to train the VHTs, avail them
with IEC material, have established health education programmes, and empower them to pass
it on to the masses at any given opportunity as envisioned in the Uganda Health Sector Strate-
gic Plan [8].
Among the service delivery and logistical challenges raised in the key informant interviews
were inadequate funds, limited drug supplies, lack of IEC material and high attrition rate of
VHTs. There is need to solve the highlighted challenges otherwise the national programme will
not fulfill its stated objectives of establishing a local demand for mass treatment [20]. There is
special effort needed to ensure that the drugs are systematically distributed at the same time to
all the islands to guarantee that every resident has the opportunity to swallow them. Despite
the highlighted success with donor funding, it was noted that the contribution from the gov-
ernment of Uganda is still low thus funds are still inadequate. The high dependence on collabo-
rative partners for the schistosomiasis control initiatives posses challenges of sustainability for
the programme.
The results have shown that individual factors such as occupation, enabling factors such as
knowledge about schistosomiasis and MDA and perceived benefits of MDA increase the likeli-
hood of MDA uptake. This is useful information for the improvement of the national schisto-
somiasis control programme with the use of mass drug administration
Study limitations
First, data on uptake was self-reported and it is possible that respondents were unable to recall
treatment correctly. Because praziquantel tablets are usually large, pungent, unpalatable and
mass treatment is an annual event, we believe that all of these enable the community members
to recall the treatment. We believe that self-report in this study is fairly accurate. Second, being
a cross sectional study, it was not possible to ascertain causality from associations between the
population factors and uptake of MDA.
Conclusions
Uptake of MDA for schistosomiasis control in Koome was sub optimal. Lack of knowledge
about schistosomiasis transmission and prevention, inadequate health education, and drug
shortages are some of the major factors associated with low uptake. These should be addressed
for the successful elimination of schistosomiasis on the islands. Further research is needed to
understand the issue of side effects, bad taste of drugs and how it relates to uptake with in this
population and also to understand how community members overcome challenges towards
MDA uptake. Through routine health education, systematic drug supply, VHT supervision
and motivation, these challenges to MDA in Koome may be overcome
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